Incumbent-intelligence read on this vehicle: who holds it, how the money has moved, and where the option runway opens the next recompete.
UNCLASSIFIED // COMPANY PROPRIETARY
Prepared August 1, 2026. Information available as of August 1, 2026. Built entirely from public federal records. All portions of this product are marked (U). Analysis is derived from public records, not verified fact; verify independently before relying on it. Handle as company proprietary.
Evidence Markings
DETERMINED: an observed fact from the public record.
INFERRED: an analytic judgment, carrying a stated confidence level.
MUST-CHECK: an intelligence gap, written as an action item for the capture team.
Confidence Scale
High: corroborated by multiple independent public sources; minimal inference.
Moderate: credibly sourced but not fully corroborated, or partial inference.
Low: fragmented, uncorroborated, or assumption-heavy.
Public preview: the holder roster and vehicle ceiling are free. A free account unlocks more; subscriptions are coming soon.Sign up freePricing
◎ Contract Vehicle SITREP
Analysis derived from public records, not verified fact. Verify independently before relying on it.
36F79718D0523
Incumbent-intelligence read on this vehicle: who holds it, how the money has moved, and where the option runway opens the next recompete.
Multi-award vehicle (MAC / GWAC / Schedule) (FSS) · Multiple award · Department of Veterans Affairs, NAC FEDERAL SUPPLY SCHEDULE (36F797)
$1.3B ceiling29 holdersNAICS 325413
§1
Bottom Line Up Front
▪What this is. 36F79718D0523 is a multi-award vehicle (mac / gwac / schedule) (FSS) issued by Department of Veterans Affairs, NAC FEDERAL SUPPLY SCHEDULE (36F797), solicitation 65VII, a multiple award vehicle with a combined ceiling of $1.3B, held by 29 primes on the public record.
▪The money. Funded totals against the $1.3B ceiling, split by prime, are a subscription read; the holder roster is on the public record below.
▪Recompete timing. No period-of-performance end is on record for this vehicle; recompete timing is not determined.
▪The read. For a challenger: the holder roster below is the field to beat, and the option runway sets the earliest realistic entry point. For an incumbent: defend the funded share and the option ladder now, and watch for deobligations or thinning competition as an early signal of a scope change.
§2
Entity Baseline
What this vehicle is and its scale, from the public contract record. Raw identifiers live here and in Sourcing; the body refers to the vehicle and its holders by name.
Vehicle
36F79718D0523
Type
Multi-award vehicle (MAC / GWAC / Schedule) (FSS)
Award structure
Multiple award
Awarding agency / office
Department of Veterans Affairs, NAC FEDERAL SUPPLY SCHEDULE (36F797)
Combined ceiling
$1.3B
Funded to date
available with subscription
Period through
n/a
Base solicitation
65VII
NAICS / PSC
325413 · PSC 6550
Vehicle ID
§3
Incumbent Baseline · Prime Roster
Every prime holder on the vehicle, from public contract award records. These are the incumbents a challenger displaces and the field most likely to defend.
🔒 Funded share, task orders, and corporate history
Funded position by prime, the fiscal-year obligation curve, order-level detail with options and deobligations, novation history, competition intensity, teaming, and how this buying office competes the category overall. Paid plans read the contract action records.
Who actually places orders under this vehicle, from public contract award records.
Agencies
No agencies with recorded orders under this vehicle yet.
Offices
No offices with recorded orders under this vehicle yet.
§6
Key Analytic Assessments
DETERMINEDHigh confidence
The incumbent roster is on the public record. This vehicle is a 29-holder multiple-award family with a combined ceiling of $1.3B, held by ABBOTT LABORATORIES INC., ABBOTT LABORATORIES INC., ABBOTT RAPID DX NORTH AMERICA LLC, ABBOTT LABORATORIES INC., INSULET CORPORATION, MAGNOLIA MEDICAL TECHNOLOGIES, INC., TRIVIDIA HEALTH, INC., CHOYCE PRODUCTS INC, LUMINEX CORP, CHOYCE PRODUCTS INC, MHC MEDICAL PRODUCTS, LLC, ALBA BIOSCIENCE, INC., MID-AMERICA TAPING & REELING INC, AVMEDICAL LLC, KANDU SUPPLIES AND SERVICES, LLC, OMNIS HEALTH, LLC, PRECISION BIOLOGIC INC, ASCENSIA DIABETES CARE US INC, DEXCOM, INC., CHOYCE PRODUCTS INC, MEDLOG SOLUTIONS LLC, SBG DISTRIBUTION LLC, POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC, CENMED ENTERPRISES INC, MHC MEDICAL PRODUCTS, LLC, LOVELL GOVERNMENT SERVICES INC., MEDIPURPOSE, INC., DIAGNOSTICS DIRECT LLC, AMITY HOLDINGS, LLC.
MUST-CHECKintelligence gap
Successor vehicle structure. Whether this vehicle re-competes as a standalone follow-on or the requirement migrates onto a different GWAC or Schedule path is not established on the public record.
MUST-CHECKintelligence gap
Teaming coverage is partial. First-tier subcontract reporting is required only above a dollar threshold and many primes under-report, so any teaming picture is a floor, not the full bench.
§7
Intelligence Gaps & Outlook
What this SITREP could not determine from the public record, consolidated. Each is an action for the capture team.
▸Exact option end and extensions. the option ladder shown reflects exercised actions on record; the contractual final option end date and any bilateral extensions are a solicitation-document pull, not a public contract-action fact.
▸Successor vehicle structure. whether this scope re-competes as a standalone follow-on, a new GWAC lane, or an existing Schedule path is unposted until the buying office publishes it.
▸Past-performance attribution on novated seats. how a recompete evaluation would score incumbency acquired by novation is an RFP and legal question, not a settled public-record fact.
▸Teaming beyond the reported floor. first-tier subcontract reporting is thresholded and under-reported; mentor-protege and joint-venture ties are not in these records.
▸Current SAM size and status of every holder. business size and socioeconomic standing reflect each holder's registration on file; confirm the current size rep for any specific target NAICS before relying on set-aside eligibility.
INFERRED
§8
Sourcing
All findings derive from public federal records, as of Sat Aug 01. Raw identifiers live here and in the Entity Baseline.
Federal contract award records (FPDS / USASpending), vehicle 36F79718D0523, contract ID CONT_IDV_36F79718D0523_3600, Department of Veterans Affairs, NAC FEDERAL SUPPLY SCHEDULE (36F797), NAICS 325413, PSC 6550, combined ceiling $1.3B.
Federal contract action records (FPDS / USASpending), incumbent holders: ABBOTT LABORATORIES INC. (contract V797P2032D, UEI L3AXXYLB3V56, ceiling $471M); ABBOTT LABORATORIES INC. (contract 36F79721D0079, UEI L3AXXYLB3V56, ceiling $329M); ABBOTT RAPID DX NORTH AMERICA LLC (contract 36F79721D0073, UEI P782RNU1NNK3, ceiling $300M); ABBOTT LABORATORIES INC. (contract 36F79721D0233, UEI L3AXXYLB3V56, ceiling $94M); INSULET CORPORATION (contract 36F79724D0022, UEI HUBSA85LEYT7, ceiling $70M); MAGNOLIA MEDICAL TECHNOLOGIES, INC. (contract 36F79724D0073, UEI KE3DWGU9NQ95, ceiling $17M); TRIVIDIA HEALTH, INC. (contract 36F79720D0027, UEI EM6VWTTDGCJ3, ceiling $16M); CHOYCE PRODUCTS INC (contract V797D70104, UEI K6T4ELQPEEG1, ceiling $8M); LUMINEX CORP (contract 36F79719D0244, UEI VLLHHV5E3AL1, ceiling $7M); CHOYCE PRODUCTS INC (contract 36F79723D0091, UEI K6T4ELQPEEG1, ceiling $7M); MHC MEDICAL PRODUCTS, LLC (contract 36F79718D0523, UEI TJL1DKTX98S5, ceiling $5M); ALBA BIOSCIENCE, INC. (contract , UEI , ceiling $4M).
◎ CONTRACT VEHICLE SITREP // UNCLASSIFIED // COMPANY PROPRIETARY
Investigate|Radar|Illustrative intelligence from public data; supports, does not replace, your capture decision. The live record on SAM and USASpending always governs.
DETERMINEDHigh confidence29 prime holder(s) on the vehicle
Moderate confidence
outlook
Short to medium term: the prime roster above defends its position on the vehicle, with the option runway setting the near-term recompete clock. The watch items that move this read are any RFP or successor-vehicle notice under this office and NAICS, new teaming that signals a bid, and a change in the funded-share leader.